25 related articles for article (PubMed ID: 34523353)
1. Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastoma.
Wang M; Bergès R; Malfanti A; Préat V; Bastiancich C
Drug Deliv Transl Res; 2023 Oct; ():. PubMed ID: 37889402
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme.
da Silva ÁC; Scholl JN; de Fraga Dias A; Weber AF; Morrone FB; Cruz-López O; Conejo-García A; Campos JM; Sévigny J; Figueiró F; Battastini AMO
Purinergic Signal; 2023 Oct; ():. PubMed ID: 37906424
[TBL] [Abstract][Full Text] [Related]
3. Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells.
Antonow MB; Franco C; Prado W; Beckenkamp A; Silveira GP; Buffon A; Guterres SS; Pohlmann AR
Nanomaterials (Basel); 2017 Dec; 8(1):. PubMed ID: 29271920
[TBL] [Abstract][Full Text] [Related]
4. The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal administration.
Labrak Y; Alhouayek M; Mwema A; d'Auria L; Ucakar B; van Pesch V; Muccioli GG; des Rieux A
Int J Pharm; 2024 May; 659():124237. PubMed ID: 38762167
[TBL] [Abstract][Full Text] [Related]
5. Novel radioiodinated desvenlafaxine-loaded lipid nanocapsule for brain delivery.
Ayoub VR; Abdel-Mottaleb MMA; Ibrahem IT; Motaleb MA; Geneidi AS
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300618. PubMed ID: 38161231
[TBL] [Abstract][Full Text] [Related]
6. Brain targeted lactoferrin coated lipid nanocapsules for the combined effects of apocynin and lavender essential oil in PTZ induced seizures.
Youssef JR; Boraie NA; Ismail FA; Bakr BA; Allam EA; El-Moslemany RM
Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38819768
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory and proliferative microglia drive progression of glioblastoma.
Liu H; Sun Y; Zhang Q; Jin W; Gordon RE; Zhang Y; Wang J; Sun C; Wang ZJ; Qi X; Zhang J; Huang B; Gui Q; Yuan H; Chen L; Ma X; Fang C; Liu YQ; Yu X; Feng S
Cell Rep; 2021 Sep; 36(11):109718. PubMed ID: 34525361
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy with anlotinib for a leptomeningeal spread recurrent glioblastoma patient.
Li C; Li W; Dai S; Sharma A; Sharma HS; Wu Y
Prog Brain Res; 2021; 265():407-414. PubMed ID: 34560927
[TBL] [Abstract][Full Text] [Related]
9. Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma.
Talele S; Zhang W; Burgenske DM; Kim M; Mohammad AS; Dragojevic S; Gupta SK; Bindra RS; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2021 Dec; 379(3):343-357. PubMed ID: 34556535
[TBL] [Abstract][Full Text] [Related]
10. Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide.
Wang N; Zhu P; Huang R; Sun L; Dong D; Gao Y
Exp Ther Med; 2021 Nov; 22(5):1246. PubMed ID: 34539842
[TBL] [Abstract][Full Text] [Related]
11. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
Bruinsmann FA; de Cristo Soares Alves A; de Fraga Dias A; Lopes Silva LF; Visioli F; Raffin Pohlmann A; Figueiró F; Sonvico F; Stanisçuaski Guterres S
Int J Pharm; 2022 Mar; 616():121563. PubMed ID: 35151819
[TBL] [Abstract][Full Text] [Related]
13. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.
Bernardi A; Frozza RL; Hoppe JB; Salbego C; Pohlmann AR; Battastini AM; Guterres SS
Int J Nanomedicine; 2013; 8():711-28. PubMed ID: 23440594
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
[TBL] [Abstract][Full Text] [Related]
15. Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma.
Fraga Dias A; Dallemole DR; Bruinsmann FA; Lopes Silva LF; Cruz-López O; Conejo-García A; Oliveira Battastini AM; Campos JM; Guterres SS; Pohlmann AR; Figueiró F
Nanomedicine (Lond); 2021 Oct; 16(23):2095-2115. PubMed ID: 34523353
[No Abstract] [Full Text] [Related]
16. New insights into cytotoxic mechanisms of bozepinib against glioblastoma.
Dias AF; Scholl JN; Moritz CEJ; Kagami LP; das Neves GM; Eifler-Lima VL; Cruz-López O; Conejo-García A; Sévigny J; Battastini AMO; Campos JM; Figueiró F
Eur J Pharm Sci; 2021 Jul; 162():105823. PubMed ID: 33781855
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
